Figure 5.

Distribution of 30-day outcomes for patients receiving nirmatrelvir/ritonavir (PaxlovidTM), Canadaa, 2022 (n=58,881)
Abbreviation: ICU, intensive care unit
a Based on data from six reporting jurisdictions

Distribution of 30-day outcomes for patients receiving nirmatrelvir/ritonavir (PaxlovidTM), Canadaa, 2022 (n=58,881)
Abbreviation: ICU, intensive care unit
a Based on data from six reporting jurisdictions